Literature DB >> 4977326

[The therapy of the paraproteinemias].

U Kanzow.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4977326     DOI: 10.1007/BF01633092

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


× No keyword cloud information.
  13 in total

1.  [TREATMENT OF KAHLER'S DISEASE WITH MELPHALAN].

Authors:  H J DIK; S I DE VRIES
Journal:  Ned Tijdschr Geneeskd       Date:  1964-07-11

2.  MULTIPLE MYELOMA. II. ANALYSIS OF CYCLOPHOSPHAMIDE THERAPY IN 165 PATIENTS.

Authors:  D R KORST; G O CLIFFORD; W M FOWLER; J LOUIS; J WILL; H E WILSON
Journal:  JAMA       Date:  1964-09-07       Impact factor: 56.272

3.  [ON THE THERAPEUTIC CONTROL OF MACROGLOBULINEMIC DISEASE PICTURES].

Authors:  D KLEMM; H SCHUBOTHE; P OBRECHT; H LANGENDORFF
Journal:  Klin Wochenschr       Date:  1963-08-15

4.  Continuous chlorambucil therapy in primary macroglobulinemia of Waldenstrom: report of four cases.

Authors:  E D BAYRD
Journal:  Proc Staff Meet Mayo Clin       Date:  1961-03-15

5.  MELPHALAN IN THE TREATMENT OF MYELOMATOSIS.

Authors:  D E SPEED; D A GALTON; A SWAN
Journal:  Br Med J       Date:  1964-06-27

6.  MYELOMA PROTEINS AND THE CLINICAL RESPONSE TO MELPHALAN THERAPY.

Authors:  D E DE BERGSAGEL; P J MIGLIORE; K M GRIFFITH
Journal:  Science       Date:  1965-04-16       Impact factor: 47.728

7.  [NEW EXPERIENCES IN PROLONGED TREATMENT OF MACROGLOBULINEMIC HEMOBLASTIC DISEASES WITH CYTOSTATIC DRUGS].

Authors:  D KLEMM
Journal:  Dtsch Med Wochenschr       Date:  1965-07-16       Impact factor: 0.628

8.  [On the therapy of plasmacytoma with the nitrogen mustard cyclophosphamide ester endoxan].

Authors:  K SCHUMACHER; J LANGE; K W FRITZ
Journal:  Munch Med Wochenschr       Date:  1962-11-02

9.  Treatment of Waldenstrom's macroglobulinemia by plasmapheresis.

Authors:  P J SCHWAB; J L FAHEY
Journal:  N Engl J Med       Date:  1960-09-22       Impact factor: 91.245

10.  MULTIPLE MYELOMA. STUDIES OF MOUSE PLASMA CELL TUMOR AND HUMAN MYELOMA RESPONSIVENESS TO CYCLOPHOSPHAMIDE (CYTOXAN).

Authors:  D R KORST; E P FRENKEL; J C NIXON
Journal:  Ann Intern Med       Date:  1964-02       Impact factor: 25.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.